• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

    29.05 +0.16 (+0.55%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 376,101
    Open 28.75
    Bid (Size) 26.67 (100)
    Ask (Size) 29.05 (5,000)
    Prev. Close 28.89
    Today's Range 28.44 - 29.12
    52wk Range 25.52 - 40.87
    Shares Outstanding 57,031,297
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Soleno Therapeutics: A Masterclass in Rare Disease Redemption and the $2.9B Exit
    The following feature explores the trajectory of Soleno Therapeutics as of April 7, 2026. Introduction On the morning of April 7, 2026, the biotechnology sector is processing one of the most... 
    Via Finterra
    Topics Economy Intellectual Property
    News headline image
    Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
    On March 31, 2026, Eli Lilly and Company (NYSE:LLY) sent shockwaves through the biotechnology sector by announcing a definitive agreement to acquire Centessa Pharmaceuticals (Nasdaq:CNTA) for a total... 
    Via MarketMinute

    Performance

    YTD
    -22.3%
    -22.3%
    1 Month
    +5.2%
    +5.2%
    3 Month
    -24.1%
    -24.1%
    6 Month
    +10.2%
    +10.2%
    1 Year
    -1.6%
    -1.6%

    More News

    Read More
    News headline image
    Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
    Via MarketMinute
    Topics Intellectual Property
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Case for Quality at a Discount ↗
    Via Chartmill
    News headline image
    Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences to Participate in Upcoming Investor Conferences
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences (HRMY) Earnings Transcript ↗
    Via The Motley Fool
    Harmony Biosciences Holdings (NASDAQ:HRMY) Reports Q4 2025 Revenue In Line, Earnings Miss Amid Pipeline Investment ↗
    Via Chartmill
    Topics Earnings
    Harmony Biosciences Holdings (NASDAQ:HRMY) Emerges as a Compelling Value and Growth Pick ↗
    Via Chartmill
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Mix of Strong Fundamentals and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    HRMY Stock Rises On Fresh FDA Approval For Wakix Tablets In Children But Wall Street Eyes Further Rally ↗
    Via Stocktwits
    News headline image
    Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    Harmony Biosciences Holdings (NASDAQ:HRMY) Emerges as a Prime GARP Investment ↗
    Via Chartmill
    Harmony Biosciences Holdings (NASDAQ:HRMY) Combines Strong Fundamentals with Bullish Technical Setup ↗
    Via Chartmill
    Harmony Biosciences Holdings (NASDAQ:HRMY) Embodies the Affordable Growth Strategy ↗
    Via Chartmill
    News headline image
    Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    News headline image
    Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    How Harmony Biosciences Can Prove Its Skeptics Wrong ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? ↗
    Via The Motley Fool
    Topics Initial Public Offering Intellectual Property
    News headline image
    I Was Shocked to Find This Value-Priced Biotech Growth Stock ↗
    Via The Motley Fool
    News headline image
    Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Harmony Biosciences Holdings, Inc. - Common Stock publicly traded?
    Yes, Harmony Biosciences Holdings, Inc. - Common Stock is publicly traded.
    What exchange does Harmony Biosciences Holdings, Inc. - Common Stock trade on?
    Harmony Biosciences Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock?
    The ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock is HRMY on the Nasdaq Stock Market
    What is the current price of Harmony Biosciences Holdings, Inc. - Common Stock?
    The current price of Harmony Biosciences Holdings, Inc. - Common Stock is 29.05
    When was Harmony Biosciences Holdings, Inc. - Common Stock last traded?
    The last trade of Harmony Biosciences Holdings, Inc. - Common Stock was at 04/13/26 04:00 PM ET
    What is the market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock?
    The market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock is 1.66B
    How many shares of Harmony Biosciences Holdings, Inc. - Common Stock are outstanding?
    Harmony Biosciences Holdings, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.